ANDA Litigation Settlements

Winter 2015

GENERICally Speaking: A Hatch Waxman Litigation Bulletin
Case Name Drug Patent No(s). Publicly Available Terms

Helsinn Healthcare SA v. Dr. Reddy’s Labs. Ltd., 11-3962 (D.N.J.)

Aloxi®(palonosetron hydrochloride for injection)

7,947,724

7,947,725

 

Dr. Reddy’s will be allowed to market generic Aloxi on Sept. 30, 2018, or earlier under undisclosed circumstances.

Remaining terms are confidential.

Oren D. Langer

Partner

Managing Partner, New York Office
Member of Executive Board

Ryan M. Schultz

Partner

Pronouns: he/him

Back to Top